X

Health Care

PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results

Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company…

BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also…

Merck (MRK) Earnings: 3Q23 Key Numbers

Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period…

ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The…

Key highlights from Thermo Fisher’s (TMO) Q3 2023 earnings results

Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2023 earnings results today. Revenue dropped 1% year-over-year to $10.57 billion.…

Earnings Summary: Highlights of Centene Corp’s Q3 2023 earnings report

Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues…

Ocean Biomedical’s chief scientist Dr. Jonathan Kurtis receives Falk Award for malaria drug candidate

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its chief scientist, Jonathan Kurtis MD, PhD has received the…

Intuitive Surgical stock dips after mixed Q3 earnings. What’s in store?

Intuitive Surgical, Inc. (NASDAQ: ISRG) produces and sells some of the most advanced robotic surgical systems that make medical procedures…

ISRG Earnings: Intuitive Surgical Q3 2023 revenues and earnings increase

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the third quarter of 2023, reporting higher revenues…

Infographic: Key highlights from Abbott Laboratories’ (ABT) Q3 2023 earnings results

Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today. Net sales decreased 2.6% year-over-year to $10.1 billion. On an…

JNJ Earnings: All you need to know about Johnson & Johnson’s Q3 2023 earnings results

Johnson & Johnson (NYSE: JNJ) reported third quarter 2023 earnings results today. Reported sales increased 6.8% year-over-year to $21.3 billion.…

Infographic: How UnitedHealth Group (UNH) performed in Q3 2023

UnitedHealth Group (NYSE: UNH) reported third quarter 2023 earnings results today. Revenues grew 14% year-over-year to $92.4 billion. Net earnings…

Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand…

Walgreens Boots Alliance (WBA) Q4 2023 Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today. Sales increased 9.2% year-over-year to $35.4 billion.…

Johnson & Johnson to report earnings on Oct 17. Here’s what to look for

After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to…

UnitedHealth earnings preview: Another beat in cards despite cost concerns

Over the years, UnitedHealth Group Incorporated (NYSE: UNH) has expanded steadily through diversification and acquisitions, all along creating value for…

What to look for when Walgreens Boots Alliance reports earnings on Oct. 12

Retail pharmacy chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is on the path to a transformation as it looks to…

Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%

AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024…

Ocean Biomedical announces loan commitment of up to $10 million from largest stockholder

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers to develop and commercialize…

Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in…

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues.…